IP Library Granted Patent US 11,034,716
Granted Patent B2
US 11,034,716 · App. 16/081,835 · Granted Jun 15, 2021

Process and new intermediates for the preparation of 11-methylene steroids

Inventors: Celso Miguel Sandoval Rodríguez (Boecillo-Valladolid, ES); Ignacio Herráiz Sierra (Boecillo-Valladolid, ES); Ivano Messina (Boecillo-Valladolid, ES); Jesús Miguel Iglesias Retuerto (Boecillo-Valladolid, ES)
Assignee: CRYSTAL PHARMA, S.A.U.
C07J11/00C07J1/0059C07J1/0096C07J21/008C07J33/007C07J43/003C07J51/00C07J1/007C07J1/0077C07J1/0085
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,034,716
App. No.
16/081,835
Granted
Jun 15, 2021
Kind
B2
Abstract

A process for the preparation of 11-methylene steroids from di-keto steroids involves selective olefination of the ketone at position 11 of the di-keto steroids. The resulting 11-methylene steroid products can be used as intermediates in the preparation of the synthetic steroids, Etonogestrel and Desogestrel, as well as other pharmaceutically active agents.

Claims (91)

1. A process for the preparation of a compound of formula (I), or a solvate thereof

wherein

X represents H or it forms together with the carbon atom to which it is bonded a ketone protecting group;

Y together with the carbon atom to which it is bonded represents C═CH 2 or C(OH)CH 2 Z, wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

R 6 is selected from H, C 1 -C 6 alkyl and halogen;

R 10 is selected from H, C 1 -C 6 alkyl and halogen, or is absent when there is a double bond between C 1 and C 10 ; R 13 is selected from H and C 1 -C 6 alkyl; R 16 is selected from H, C 1 -C 6 alkyl and halogen;

- - - is a single or double bond;

which comprises reacting a compound of formula (II) or a solvate thereof

wherein X, R 6 , R 10 , R 13 , R 16 , and - - - have the meanings defined above;

with a compound of formula (III)

wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl and M is selected from Li, MgBr, MgCl and Mgl.

2. The process according to claim 1 , wherein R 6 , R 10 , R 16 are H; and R 13 is selected from C 1 -C 6 alkyl.

3. The process according to claim 1 , wherein Z represents a SiR′ 3 group wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl.

4. The process according to claim 1 , wherein Y together with the carbon atom to which it is bonded represents C═CH 2 .

5. The process according to claim 4 , which comprises:

(a) reacting a compound of formula (II), or a solvate thereof, with a compound of formula (III) to obtain a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 , wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl; and

(b) treating a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 , wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl, with an acid or a base to obtain a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents C═CH 2 .

6. The process according to claim 1 , which further comprises ethynylating the compound of formula (I), or a solvate thereof, to obtain a compound of formula (IV), or a solvate thereof

wherein

Y, R 6 , R 10 , R 13 , R 16 and - - - are as defined in claim 1 ;

X represents H or it forms together with the carbon atom to which it is bonded a ketone group or a ketone protecting group; and

R 1 is selected from H and SiR″ 3 , wherein each R″ is independently selected from C 1 -C 6 alkyl, C 6 -C 10 aryl and halogen.

7. The process according to claim 6 , which comprises:

(a) reacting a compound of formula (II), or a solvate thereof, with a compound of formula (III) to obtain a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

(b) treating a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 , wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl, with an acid or a base to obtain a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents C═CH 2 ; and

(c) ethynylating a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents C═CH 2 , to obtain a compound of formula (IV), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents C═CH 2 .

8. The process according to claim 7 , which comprises:

(a) reacting a compound of formula (II), or a solvate thereof, with a compound of formula (III) to obtain a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 , wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

(b) ethynylating a compound of formula (I), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl, to obtain a compound of formula (IV), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl; and

(c) treating a compound of formula (IV), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents a C(OH)CH 2 Z group, wherein Z is selected from H and SiR′ 3 , wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl, with an acid or a base to obtain a compound of formula (IV), or a solvate thereof, wherein Y together with the carbon atom to which it is bonded represents C═CH 2 .

9. A process for the preparation of Desogestrel, Etonogestrel, or a solvate thereof, the process comprising:

preparing a compound of formula (I) or a solvate thereof

wherein

X represents H or it forms together with the carbon atom to which it is bonded a ketone protecting group;

Y together with the carbon atom to which it is bonded represents C═CH 2 or C(OH)CH 2Z , wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

R 6 is selected from H, C 1 -C 6 alkyl and halogen;

R 10 is selected from H, C 1 -C 6 alkyl and halogen, or is absent when there is a double bond between C 1 and C 10 ;R 13 is selected from H and C 1 -C 6 alkyl; R 16 is selected from H, C 1 -C 6 alkyl and halogen;

- - - is a single or double bond;

by reacting a compound of formula (II) or a solvate thereof

wherein X, R 6 , R 10 , R 13 , R 16 , and - - - have the meanings defined above;

with a compound of formula (III)

wherein Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl and M is selected from Li, MgBr, MgCI and MgI; and

converting the compound of formula (I), or a solvate thereof to Desogestrel, Etonogestrel, or a solvate thereof.

10. The process according to claim 9 , wherein converting to Etonogestrel, or a solvate thereof, comprises the following steps:

(a) reacting a compound of formula (IIa), or a solvate thereof,

wherein

X forms together with the carbon atom to which it is bonded a ketone protecting group; and

- - - is a single or double bond;

with a compound of formula (III)

wherein

M is selected from Li, MgBr, MgCl and MgI; and

Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

to afford a compound of formula (Ia-1) or a solvate thereof

(b) treating a compound of formula (Ia-1), or a solvate thereof, with an acid or a base to afford a compound of formula (Ia-2), or a solvate thereof,

(c) ethynylating a compound of formula (Ia-2), or a solvate thereof, to afford a compound of formula (IVa-1), or a solvate thereof

wherein

X forms together with the carbon atom to which it is bonded a ketone group or a ketone protecting group

R 1 is selected from H and SiR″ 3 , wherein each R″ is independently selected from C 1 -C 6 alkyl, C 6 -C 10 aryl and halogen; and

(d) if necessary, carrying out one or both of the following steps in any order:

(i) if X forms together with the carbon atom to which it is bonded a ketone protecting group, cleavage of the ketone protecting group to afford a compound of formula (IVa-1), or a solvate thereof, wherein X forms together with the carbon atom to which it is bonded a ketone group,

(ii) if R 1 is a SiR″ 3 group, removal of the SiR″ 3 group to afford a compound of formula (IVa-1), or a solvate thereof, wherein R 1 is H.

11. The process according to claim 9 , wherein converting to Etonogestrel, or a solvate thereof, comprises the following steps:

(a) reacting a compound of formula (IIa), or a solvate thereof,

wherein

X forms together with the carbon atom to which it is bonded a ketone protecting group; and

- - - is a single or double bond;

with a compound of formula (III)

wherein

M is selected from Li, MgBr, MgCl and MgI; and

Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

to afford a compound of formula (Ia-1), or a solvate thereof,

(b) ethynylating a compound of formula (Ia-1), or a solvate thereof, to afford a compound of formula (IVa-2), or a solvate thereof

wherein R 1 is selected from H and SiR″ 3 , wherein each R″ is independently selected from C 1 -C 6 alkyl, C 6 -C 10 aryl and halogen;

(c) treating a compound of formula (IVa-2), or a solvate thereof, with an acid or a base to afford a compound of formula (IVa-1), or a solvate thereof

wherein

X forms together with the carbon atom to which it is bonded a ketone group or a ketone protecting group

R 1 is selected from H and SiR″ 3 , wherein each R″ is independently selected from C 1 -C 6 alkyl, C 6 -C 10 aryl and halogen; and

(d) if necessary, carrying out one or both of the following steps in any order:

(i) if X forms together with the carbon atom to which it is bonded a ketone protecting group, cleavage of the ketone protecting group to afford a compound of formula (IVa-1), or a solvate thereof, wherein X forms together with the carbon atom to which it is bonded a ketone group,

(ii) if R 1 is a SiR″ 3 group, removal of the SiR″ 3 group to afford a compound of formula (IVa-1), or a solvate thereof, wherein R 1 is H.

12. The process according to claim 9 , wherein converting to Desogestrel, or a solvate thereof, comprises the following steps:

(a) reacting compound (12), or a solvate thereof,

with a compound of formula (III)

wherein

M is selected from Li, MgBr, MgCl and MgI; and

Z is selected from H and SiR′ 3 wherein each R′ is independently selected from C 1 -C 6 alkyl and C 6 -C 10 aryl;

to afford a compound of formula (Ib-1) or a solvate thereof

(b) treating a compound of formula (Ib-1), or a solvate thereof, with an acid or a base to afford a compound of formula (Ib-2), or a solvate thereof,

(c) ethynylating a compound of formula (Ib-2), or a solvate thereof, to afford a compound of formula (IVb-1), or a solvate thereof

wherein R 1 is selected from H and SiR″ 3 , wherein each R″ is independently selected from C 1 -C 6 alkyl, C 6 -C 10 aryl and halogen; and

(d) if R 1 is a SiR″ 3 group, removing SiR″ 3 group to afford Desogestrel, or a solvate thereof.

Assignments (5)
CHANGE OF NAME Recorded Nov 5, 2025
From: CRYSTAL PHARMA, S.A.U.
To: CURIA SPAIN, S.A.U.
Reel/Frame 073449/0630 →
DECLARATION OF EQUIVALENCE Recorded Dec 3, 2020
From: CRYSTAL PHARMA S.A.
To: CRYSTAL PHARMA, S.A.U.
Reel/Frame 054585/0428 →
MERGER Recorded Nov 11, 2020
From: BIONICE SL
To: CRYSTAL PHARMA SA
Reel/Frame 054341/0894 →
DECLARATION OF EQUIVALENCE Recorded Nov 11, 2020
From: BIONICE, S.L.U
To: BIONICE SL
Reel/Frame 054385/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2018
From: SANDOVAL RODRÍGUEZ, CELSO MIGUEL; HERRÁIZ SIERRA, IGNACIO; IGLESIAS RETUERTO, JESÚS MIGUEL; MESSINA, IVANO
To: BIONICE, S.L.U
Reel/Frame 047467/0059 →